Efthymios Deliargyris

Insider Reports History

Entity
Individual
Location
C/O Plx Pharma,Inc.8285 El Rio Street, Suite 210, Houston, TX
Signature
/s/ Efthymios Deliargyris
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Efthymios Deliargyris:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cytosorbents Corp Chief Medical Officer Common Stock 403K $403K $1.00 Jan 17, 2025 Direct
Cytosorbents Corp Chief Medical Officer Stock Option (Right to Buy) 50K Oct 4, 2024 Direct
Cytosorbents Corp Chief Medical Officer Series A Right Warrants 16.2K Jan 17, 2025 Direct
Cytosorbents Corp Chief Medical Officer Series B Right Warrants 16.2K Jan 17, 2025 Direct
Cytosorbents Corp Chief Medical Officer Subscription Rights (right to buy) 0 Jan 17, 2025 Direct

Insider Reports Filed by Efthymios Deliargyris

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTSO Cytosorbents Corp Jan 17, 2025 4 $16.2K 4 Jan 22, 2025 Chief Medical Officer
CTSO Cytosorbents Corp Oct 4, 2024 2 $0 4 Oct 8, 2024 Chief Medical Officer
CTSO Cytosorbents Corp Apr 2, 2024 2 $0 4 Apr 4, 2024 Chief Medical Officer
CTSO Cytosorbents Corp Mar 29, 2024 1 $0 4 Apr 2, 2024 Chief Medical Officer
CTSO Cytosorbents Corp Dec 13, 2023 2 $30K 4 Dec 15, 2023 Chief Medical Officer
CTSO Cytosorbents Corp Jul 7, 2023 3 $0 4 Jul 11, 2023 Chief Medical Officer
CTSO Cytosorbents Corp Aug 10, 2022 4 $0 4 Aug 12, 2022 Chief Medical Officer